Prescription drug · ANDA
Quetiapine Fumarate ER NDC 72189-642
Quetiapine fumarate 400 mg/1 · Tablet, Extended release · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-642-30 | 7218906423072189064230 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-642-30)Marketed from Sep 26, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Quetiapine Fumarate ER
- Generic name (nonproprietary)
- quetiapine fumarate er
- Active ingredients
- Quetiapine fumarate — 400 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Direct_RxNDC labeler code 72189
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204253
- Marketing start
- Listing expires
- Identifiers
- Product ID 72189-642_3fb5c81f-ce60-98bf-e063-6294a90a5711SPL ID 3fb5c81f-ce60-98bf-e063-6294a90a5711SPL set ID 3fb5c81f-ce5f-98bf-e063-6294a90a5711RxCUI 721796UNII 2S3PL1B6UJ
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189064230followed by a unit qualifier and the quantityPackage 72189-0642-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
1.1 Schizophrenia Quetiapine extended-release tablets are indicated for the treatment of schizophrenia. The efficacy of quetiapine extended-release tablets in schizophrenia was established in one 6-week and one maintenance trial in adults with schizophrenia. Efficacy was supported by three 6-week trials in adults with schizophrenia and one 6-week trial in adolescents with schizophrenia (13 to 17 years) treated with quetiapine [see Clinical Studies (14.1) ]. 1.2 Bipolar Disorder Quetiapine extended-release tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex. The efficacy of …
Excerpt only. Read the full label for complete information.
About NDC 72189-642
- What is NDC 72189-642?
- 72189-642 is the product NDC for Quetiapine Fumarate ER, Quetiapine fumarate 400 mg/1 tablet, extended release, listed with the FDA by Direct_Rx. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Quetiapine Fumarate ER.
- What is the active ingredient?
- Quetiapine fumarate.
- Who is the labeler?
- Direct_Rx, NDC labeler code 72189. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Quetiapine Fumarate ER?
- 5 other product NDCs are listed under this name. See all Quetiapine Fumarate ER NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Quetiapine Fumarate ER products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Quetiapine Fumarate ER | Quetiapine fumarate 150 mg/1 | Tablet, Film coated, Extended releaseOral | Direct_rx | 72189-586 | 72189-0586-30 |
| Quetiapine Fumarate ER | Quetiapine fumarate 200 mg/1 | Tablet, Film coated, Extended releaseOral | Direct_Rx | 72189-519 | 72189-0519-30 |
| Quetiapine Fumarate ER | Quetiapine fumarate 150 mg/1 | Tablet, Extended releaseOral | Direct_Rx | 72189-481 | 72189-0481-30 |
| Quetiapine Fumarate ER | Quetiapine fumarate 200 mg/1 | Tablet, Extended releaseOral | Direct_Rx | 72189-482 | 72189-0482-30 |
| Quetiapine Fumarate ER | Quetiapine fumarate 400 mg/1 | Tablet, Extended releaseOral | Direct_Rx | 72189-483 | 72189-0483-30 |
Other NDCs under ANDA 204253
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Quetiapine | Quetiapine fumarate 150 mg/1 | Tablet, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-134 |
| Quetiapine | Quetiapine fumarate 200 mg/1 | Tablet, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-135 |
| Quetiapine | Quetiapine fumarate 300 mg/1 | Tablet, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-136 |
| Quetiapine | Quetiapine fumarate 400 mg/1 | Tablet, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-137 |
| Quetiapine | Quetiapine fumarate 400 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 63629-5944 |
| Quetiapine | Quetiapine fumarate 200 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4699 |
| Quetiapine | Quetiapine fumarate 400 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4700 |